These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15617347)

  • 1. [Experimental comparison of two coxsackievirus B3 variants in murine myocardial cells].
    Cui X; Gomez R; Sun G; Ma L; Xu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):274-6. PubMed ID: 15617347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
    Weller AH; Simpson K; Herzum M; Van Houten N; Huber SA
    J Immunol; 1989 Sep; 143(6):1843-50. PubMed ID: 2550544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK; Gauntt CJ
    J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
    Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
    Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.
    Godeny EK; Gauntt CJ
    J Immunol; 1986 Sep; 137(5):1695-702. PubMed ID: 3018079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
    J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
    Estrin M; Smith C; Huber S
    Am J Pathol; 1986 Dec; 125(3):578-84. PubMed ID: 2432792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
    Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
    Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
    J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
    Lee C; Maull E; Chapman N; Tracy S; Gauntt C
    J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.
    Gauntt CJ; Trousdale MD; LaBadie DR; Paque RE; Nealon T
    J Med Virol; 1979; 3(3):207-20. PubMed ID: 225441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus B3 infection leads to cell death of cardiac myocytes.
    Herzum M; Ruppert V; Küytz B; Jomaa H; Nakamura I; Maisch B
    J Mol Cell Cardiol; 1994 Jul; 26(7):907-13. PubMed ID: 7966359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MIP-2 in coxsackievirus B3 myocarditis.
    Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
    J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus B3 genomes detected by polymerase chain reaction: evidence of latent persistency in the myocardium in experimental murine myocarditis.
    Adachi K; Muraishi A; Seki Y; Yamaki K; Yoshizuka M
    Histol Histopathol; 1996 Jul; 11(3):587-96. PubMed ID: 8839749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a C-type CpG ODN on CVB3-infected mice].
    Yang L; Sun WQ; Wang L; Wang XL; Wan M; Yu YL; Wang LY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):115-7. PubMed ID: 19174007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of Chinese herbal medicine Xin-kang oral liquid on interferon-induction and its antiviral activity in coxsackievirus B3 infected mice].
    Wan SJ; Li JN; Zhao H; Wang LX; Huang XZ; Zhu Y; Chen HS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):77-9. PubMed ID: 16201482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.